SCHEMBL20724699

SCHEMBL20724699

CCOC(=O)C(CCC(=O)Nc1ccc(Nc2ccccc2)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 2/20 0.50
LTA4H P09960 2/20 0.49
TSHR P16473 1/20 0.48
GAA P10253 2/20 0.46
RAB9A P51151 1/20 0.46
ACE P12821 1/20 0.46
HTT P42858 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HDAC8 Q9BY41 1/20 0.45
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
CTSK P43235 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
BCHE P06276 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20255053 0.91 LTA4H (0.51) MAPTALDH1A1HPGDLTA4HTSHR
SCHEMBL25181350 0.87 KLK5 (0.50) LTA4HACEHDAC8PPARGPPARA
SCHEMBL23834107 0.87 KLK5 (0.50) LTA4HACEHDAC8PPARGPPARA
SCHEMBL31407356 0.86 ACE (0.56) ALDH1A1LTA4HTSHRGAAACE
SCHEMBL20253488 0.81 LTA4H (0.55) HPGDLTA4HRAB9AHDAC8MAPK1
SCHEMBL20253474 0.81 LTA4H (0.59) LTA4HACEHDAC8PPARGPPARA
SCHEMBL13325459 0.80 LTA4H (0.47) MAPTALDH1A1LTA4HACECYP1A2
SCHEMBL28286842 0.80 ALDH1A1 (0.58) MAPTALDH1A1HPGDGAAACE
SCHEMBL28286840 0.80 ALDH1A1 (0.58) MAPTALDH1A1HPGDGAAACE
SCHEMBL20253475 0.80 LTA4H (0.58) LTA4HACEHDAC8PPARACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202334-B2 Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase CELTAXSYS, INC. (US) 2019-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10202334-B2 Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase LTA4H, LTB4R, LTC4S MAPT 2828/4885ALDH1A1 511/4885HPGD 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.